DexCom Inc (DXCM.O)

DXCM.O on Nasdaq

44.21USD
28 Aug 2014
Price Change (% chg)

$-0.07 (-0.16%)
Prev Close
$44.28
Open
--
Day's High
--
Day's Low
--
Volume
197,487
Avg. Vol
711,929
52-wk High
$49.83
52-wk Low
$25.49

DXCM.O

Chart for DXCM.O

About

DexCom, Inc. (DexCom) is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The Company had received... (more)

Overall

Beta: 0.41
Market Cap (Mil.): $3,336.04
Shares Outstanding (Mil.): 75.48
Dividend: --
Yield (%): --

Financials

  DXCM.O Industry Sector
P/E (TTM): -- 32.54 33.56
EPS (TTM): -0.37 -- --
ROI: -29.25 10.16 17.31
ROE: -31.53 12.04 18.05
Search Stocks

Competitors

  Price Change
Roche Holding Ltd. (ROG.VX) CHF267.70 +0.60
Johnson & Johnson (JNJ.N) $103.73 +0.78
Abbott Laboratories (ABT.N) $42.24 -0.11
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Medtronic, Inc. (MDT.N) $63.85 +0.73

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks